Results 71 to 80 of about 1,130 (117)

Avapritinib and corticosteroids in advanced systemic mastocytosis with tumoral CMML and associated thrombocytopenia. [PDF]

Oxf Med Case Reports
Abakarim O, Jeddi R, Rossignol J, Hermine O, Delabesse E, Condom P, Laurent C, Botin T.   +7 more
europepmc   +1 more source

Microglia in diffuse midline glioma contribute to extracellular matrix remodelling and cancer cell invasion. [PDF]

Cell Death Dis
Keane L, Škandík M, Posada-Pérez M, Bose R, Desito J, van der Linde E, Engskog-Vlachos P, Ceccatelli S, Green AL, Joseph B.   +9 more
europepmc   +1 more source

The Evolving Role of Second- and Third-Generation Tyrosine Kinase Inhibitors in Gastrointestinal Malignancies: Advances in Targeted Therapy with Sunitinib, Regorafenib, and Avapritinib. [PDF]

J Clin Med
Kawczak P, Bączek T.
europepmc   +1 more source

[Efficacy and safety analysis of avapritinib in children with RUNX1::RUNX1T1 positive-acute myeloid leukemia with KIT mutations]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Zheng FY, Ding MM, Lu AD, Jia YP, Zeng HM, Zhang LP.   +5 more
europepmc   +1 more source

Sustainable high-throughput microwell spectrophotometric methods for avapritinib quality control via charge-transfer complexation. [PDF]

Sci Rep
Ali AM, Alsalhi MS, Othman WM, Frontera A, Alahmad W, Darwish IA.   +5 more
europepmc   +1 more source

Nemolizumab as an Alternative Therapeutic Option for Indolent Systemic Mastocytosis. [PDF]

Cureus
Minbaeva S, Tyring SK.
europepmc   +1 more source

In-silico identification of genetic variants associated with chronic lymphocytic leukemia for diagnostic and therapeutic applications. [PDF]

Sci Rep
Islam MS, Mollah MMH, Ahsan MA, Ali M, Al Noman M, Ahmed MF, Latif MA, Pal NK, Faysal MF, Mollah MNH.   +9 more
europepmc   +1 more source

Molecular Pathogenesis and Targeted Therapies for Myeloproliferative Hypereosinophilic Neoplasms. [PDF]

Curr Hematol Malig Rep
Hanna C, Rizkallah J, Charbel N, Sakkal S, Haddad FG.   +4 more
europepmc   +1 more source

Advances in the Management of Mediator-Related Symptoms in Non-Advanced Systemic Mastocytosis. [PDF]

Immunotargets Ther
Gülen T, Sabato V.
europepmc   +1 more source

Systemic Mastocytosis, KIT and the Effects of KIT Tyrosine Kinase Inhibitors on Mast Cell and Basophil Activation. [PDF]

Curr Allergy Asthma Rep
Valent P, Hartmann K, Stefanzl G, Filik Y, Bauer K, Degenfeld-Schonburg L, Gleixner KV, Siebenhaar F, Niedoszytko M, Sperr WR, Aghaallaei N, Hoermann G, Sabato V, Orfao A, Arock M, Akin C.   +15 more
europepmc   +1 more source